Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

WP3 - Severe Autoimmune Diabetes (SAID) - mechanisms & pathways

WP leaders
 

Åke Lernmark and Annelie Carlsson

Objectives

  • To explore the influence of SAID heterogeneity on disease outcome
  • To identify targetable mechanisms and pathways underlying initiation and progression of SAID
  • To identify predictive biomarkers for the development of other concomitant autoimmune disease

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Press releases

Publications

DiaUnion, the Medicon Valley Center for diabetes, autoimmunity and prevention

  • Started in winter 2020, will run for 2.5 years
  • Funded by the European Regional Development Fund
  • Partners are Lund University, Steno Diabetes Center Copenhagen, Medicon Valley Alliance, The Capital Region of Denmark and Region Skåne
  • https://mva.org/projects/diaunion/